Vor to present new platform and preclinical data at ash

Cambridge, mass., nov. 04, 2021 (globe newswire) -- vor biopharma (nasdaq: vor), a clinical-stage cell and genome engineering company, today announced the upcoming presentation of new data from its novel engineered hematopoietic stem cell (ehsc) platform at the american society of hematology (ash) 63rd annual meeting, taking place in atlanta, georgia from december 11-14, 2021.
VOR Ratings Summary
VOR Quant Ranking